Document is current
Any future updates will be listed below
-
Authors
Auer-Hackenberg, Lorenz https://orcid.org/0000-0002-5634-5791
Brandner, Johannes
Hofstätter, Edda
Stroicz, Patricia
Hager, Tobias
Eichhorn, Anna
Schütz, Sebastian
Feldner, Raphael
Wald, Martin
-
Funding
Funding for this research was provided by:
chiesi foundation (chiesi foundation)
- License Information
-
More Information
Article History
Received: 8 September 2021
Accepted: 25 October 2022
First Online: 4 November 2022
Declarations
:
: This study protocol was reviewed and approved by the ethics committee of Salzburg (federal ethics committee Salzburg government, Sebastian-Stief-Gasse 2 5020 Salzburg), approval number 415-E/2532/7–2019 and registered as a medical device study at the Austrian Federal Office for Safety in Health Care (Ministry of Social Affairs and Health). As a study using human participants, written informed consent was obtained from participants (or their parent/legal guardian/next of kin) to participate in the study. All authors adhered to the Declaration of Helsinki and Good Clinical Practice Standards.
: Not applicable.
: Martin Wald received fees for congress talks in the last three years and sponsorship for annual respiratory care workshops by Chiesi (Chiesi Farmaceutici S.p.a. Italy). All other authors (Lorenz Auer-Hackenberg, Johannes Brandner, Tobias Hager, Anna Eichhorn, Patricia Stroicz, Edda Hofstätter, Sebastian Schütz, Raphael Feldner) have no conflicts of interest to declare.
